Development of a Clinical and Biological Database in Peritoneal Carcinosis (BCB CARCINOSE)

Development of a Clinical and Biological Database Monocentric and Prospective in Peritoneal Carcinosis

The creation of a prospective clinical-biological base dedicated to peritoneal carcinosis must therefore be able to serve as a support for this essential search for transfer.

The main objective is to improve the knowledge of carcinosis mechanisms to develop a specific treatment.

That's why this blood collection and tissue collection is very important for the future, these collection will be permitted to the scientists to develop a research specially for carcinosis.

Inclusion Criteria:

• Patient over the age of 18;
• Patient managed for peritoneal carcinosis : digestives origins (pancreatic, gastroesophageal junction, colorectal, bowel) or peritoneum cancer
• Patient eligible for a peritoneal carcinosis treatment : at least one (or more) surgery (s) ;chemotherapy or any treatment for this disease
• Patient agree will all study procedure : biological samples & tissues samples
• Patient giving informed consent

Exclusion Criteria:

• Patient not affiliated to Social Protection system
• Patient unable to understand or comply with study instructions or requirements for psychological, family, social or geographical reasons
• The level of French is insufficient to consent to the study and to response to the questionnaires
• Patient under guardianship
• Pregnancy ou breast-feeding women
• Patient treated in case of an emergency